Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.249ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.249ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.249EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.249EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.249ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.249ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.378EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.378EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.378ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.378ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.378EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.378EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.378ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.378ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.97EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.97EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.97ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.97ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.97EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.97EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.97ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.97ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.406EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.406EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.406ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.406ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.406EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.406EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.406ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.69EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.69ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.69ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used